Notice of AGM and Change of Auditor

Summary by AI BETAClose X

CT Healthcare Trust plc has announced its Notice of Annual General Meeting 2026, which will be held on April 28, 2026, and has also appointed BDO LLP as its new external auditor, replacing Ernst & Young LLP. A resolution to approve BDO's appointment will be presented at the meeting.

Disclaimer*

CT Healthcare Trust PLC
27 March 2026
 

CT Healthcare Trust plc

("the Company")

(Formerly Bellevue Healthcare Trust plc)

 

Notice of Annual General Meeting 2026

The Company announces that its Notice of Annual General Meeting 2026 (the 'Notice') is available to view on the Company's website: www.columbiathreadneedle.co.uk/ct-healthcare-trust/document-centre/

 

The Company's Annual General Meeting 2026 will be held at the offices of Hogan Lovells International LLP, Atlantic House, Holborn Viaduct, London EC1A 2FG on 28 April 2026 at 12 noon.

 

A copy of the Notice has been posted to those shareholders who have requested to receive hard copy documents and is available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism    

 

 

Change of Auditor

Following a competitive tender process, led by the Company's Audit and Risk Committee, the Board has approved the appointment of BDO LLP ("BDO") as the Company's new external auditor. A resolution to approve the appointment of BDO will be proposed at the Company's Annual General Meeting.

Ernst & Young LLP ("EY") has ceased to be the Company's auditor and has confirmed to the Company that there are no matters connected with its ceasing to hold office that need to be brought to the attention of the members or creditors of the Company for the purposes of section 519 of the Companies Act 2006.

The Company wishes to thank EY for their services over the years and their continued support.

 

Enquiries:

NSM Funds (UK) Limited

Company Secretary

+44 (0) 20 3697 5770

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings